Clinical Implications of Switching Lipid Lowering Treatment from Rosuvastatin to Other Agents in Primary Care

INTRODUCTION: Switching from any statin to another non-equipotent lipid lowering treatment (LLT) may cause a low-density lipoprotein cholesterol increase and has been associated with a higher probability of negative cardiovascular outcomes. The aim of the study was to assess the impact of switching...

Descripción completa

Detalles Bibliográficos
Autores principales: Colivicchi, Furio, Gulizia, Michele Massimo, Franzini, Laura, Imperoli, Giuseppe, Castello, Lorenzo, Aiello, Alessandro, Ripellino, Claudio, Cataldo, Nazarena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083763/
https://www.ncbi.nlm.nih.gov/pubmed/27671328
http://dx.doi.org/10.1007/s12325-016-0412-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083763/
https://www.ncbi.nlm.nih.gov/pubmed/27671328
http://dx.doi.org/10.1007/s12325-016-0412-8

Ejemplares similares